isocarboxazid has been researched along with Appetite Disorders in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Excerpt | Relevance | Reference |
---|---|---|
"In an open prospective clinical study, 14 female outpatients with anorexia nervosa or bulimia completed a 6-week trial of isocarboxazid, with a mean dose of 34 mg." | 7.67 | Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. ( Garfinkel, PE; Kennedy, SH; Piran, N, 1985) |
"In an open prospective clinical study, 14 female outpatients with anorexia nervosa or bulimia completed a 6-week trial of isocarboxazid, with a mean dose of 34 mg." | 3.67 | Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. ( Garfinkel, PE; Kennedy, SH; Piran, N, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kronig, MH | 1 |
Kennedy, SH | 1 |
Piran, N | 1 |
Garfinkel, PE | 1 |
2 other studies available for isocarboxazid and Appetite Disorders
Article | Year |
---|---|
Case report of successful treatment of bulimia with isocarboxazid.
Topics: Adult; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Isocarboxazid; Tranylcypromine | 1986 |
Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid.
Topics: Adolescent; Adult; Anorexia Nervosa; Attitude to Health; Body Weight; Depressive Disorder; Feeding a | 1985 |